Isabel Kalofonos, Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 2,500 shares at $55.00 ($138K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Open-market sale of $138k CRNX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.